Homo sapiens Protein: GHR
Summary
InnateDB Protein IDBP-18936.7
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol GHR
Protein Name growth hormone receptor
Synonyms GHBP;
Species Homo sapiens
Ensembl Protein ENSP00000350335
InnateDB Gene IDBG-18930 (GHR)
Protein Structure
UniProt Annotation
Function Receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway (By similarity). {ECO:0000250}.The soluble form (GHBP) acts as a reservoir of growth hormone in plasma and may be a modulator/inhibitor of GH signaling.Isoform 2 up-regulates the production of GHBP and acts as a negative inhibitor of GH signaling.
Subcellular Localization Cell membrane; Single-pass type I membrane protein. Note=On growth hormone binding, GHR is ubiquitinated, internalized, down-regulated and transported into a degradative or non-degradative pathway. {ECO:0000250}.Isoform 2: Cell membrane; Single-pass type I membrane protein. Note=Remains fixed to the cell membrane and is not internalized.Growth hormone-binding protein: Secreted. Note=Complexed to a substantial fraction of circulating GH. {ECO:0000250}.
Disease Associations Laron syndrome (LARS) [MIM:262500]: A severe form of growth hormone insensitivity characterized by growth impairment, short stature, dysfunctional growth hormone receptor, and failure to generate insulin-like growth factor I in response to growth hormone. {ECO:0000269PubMed:10870033, ECO:0000269PubMed:14678285, ECO:0000269PubMed:2779634, ECO:0000269PubMed:8137822, ECO:0000269PubMed:8421103, ECO:0000269PubMed:8504296, ECO:0000269PubMed:9024232, ECO:0000269PubMed:9661642, ECO:0000269PubMed:9851797}. Note=The disease is caused by mutations affecting the gene represented in this entry.Short stature, idiopathic, autosomal (ISSA) [MIM:604271]: A condition defined by a standing height more than 2 standard deviations below the mean (or below the 2.5 percentile) for sex and chronological age, compared with a well-nourished, genetically relevant population, in the absence of specific causative disorders. {ECO:0000269PubMed:7565946}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity Expressed in various tissues with high expression in liver and skeletal muscle. Isoform 4 is predominantly expressed in kidney, bladder, adrenal gland and brain stem. Isoform 1 expression in placenta is predominant in chorion and decidua. Isoform 4 is highly expressed in placental villi. Isoform 2 is expressed in lung, stomach and muscle. Low levels in liver.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 57 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated
Total 57 [view]
Protein-Protein 57 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
GO:0017046 peptide hormone binding
GO:0019838 growth factor binding
GO:0019901 protein kinase binding
GO:0042803 protein homodimerization activity
GO:0070064 proline-rich region binding
Biological Process
GO:0000187 activation of MAPK activity
GO:0000255 allantoin metabolic process
GO:0006101 citrate metabolic process
GO:0006103 2-oxoglutarate metabolic process
GO:0006105 succinate metabolic process
GO:0006107 oxaloacetate metabolic process
GO:0006549 isoleucine metabolic process
GO:0006573 valine metabolic process
GO:0006600 creatine metabolic process
GO:0006631 fatty acid metabolic process
GO:0006897 endocytosis
GO:0007259 JAK-STAT cascade
GO:0019221 cytokine-mediated signaling pathway
GO:0019530 taurine metabolic process
GO:0031623 receptor internalization
GO:0032355 response to estradiol
GO:0032870 cellular response to hormone stimulus
GO:0040014 regulation of multicellular organism growth
GO:0040018 positive regulation of multicellular organism growth
GO:0042517 positive regulation of tyrosine phosphorylation of Stat3 protein
GO:0042523 positive regulation of tyrosine phosphorylation of Stat5 protein
GO:0042977 activation of JAK2 kinase activity
GO:0044236 multicellular organismal metabolic process
GO:0046449 creatinine metabolic process
GO:0046898 response to cycloheximide
GO:0048009 insulin-like growth factor receptor signaling pathway
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
GO:0060396 growth hormone receptor signaling pathway
GO:0060397 JAK-STAT cascade involved in growth hormone signaling pathway
Cellular Component
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0009986 cell surface
GO:0016021 integral component of membrane
GO:0043235 receptor complex
GO:0070195 growth hormone receptor complex
Protein Structure and Domains
PDB ID
InterPro IPR003961 Fibronectin, type III
IPR015152 Growth hormone/erythropoietin receptor, ligand binding
PFAM PF00041
PF01108
PF09067
PRINTS
PIRSF
SMART SM00060
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P10912
PhosphoSite PhosphoSite-P10912
TrEMBL Q9HCW9
UniProt Splice Variant
Entrez Gene 2690
UniGene Hs.714143
RefSeq NP_001229389
HUGO HGNC:4263
OMIM 600946
CCDS CCDS56364
HPRD 02971
IMGT
EMBL AC093225 AC113368 AC114941 AC116343 AJ278681 AJ295613 M28458 M28459 M28460 M28461 M28462 M28463 M28464 M28465 M28466 X06562
GenPept AAA52555 CAA29808 CAC06613 CAC06615